Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Combo PharmaASX:S66 35 Days Inventory is 88.17 as of Dec. 2025, which is 13% below its 10-year median of 101.72. GuruFocus rates ASX:S66 with a GF Score™ of 35/100 and a GF Value™ of A$0.13 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,874 Consumer Packaged Goods companies, Star Combo Pharma ranks worse than 56.72% on this metric.
The historical rank and industry rank for Star Combo Pharma's Days Inventory or its related term are showing as below:
ASX:S66'
s Days Inventory Range Over the Past 10 Years
Min: 56.13 Med: 101.72 Max: 174.01
Current: 93.03
During the past 9 years, Star Combo Pharma's highest Days Inventory was 174.01. The lowest was 56.13. And the median was 101.72.
ASX:S66's Days Inventory is ranked worse than 56.72% of 1874
companies
in the Consumer Packaged Goods industry
Industry Median: 83.04
vs ASX:S66: 93.03
Star Combo Pharma's Days Inventory
increased
from Dec. 2024 (78.09) to Dec. 2025 (88.17).
It might indicate that Star Combo Pharma's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Star Combo Pharma's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.07.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Star Combo Pharma's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.36.
Star Combo Pharma (ASX:S66) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Star Combo Pharma's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Star Combo Pharma's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Star Combo Pharma Days Inventory Related Terms
Star Combo Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Star Combo Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:S66 vs PG, CL, KVUE: Days Inventory Comparison
For the Household & Personal Products subindustry, Star Combo Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Combo Pharma Days Inventory vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Star Combo Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Star Combo Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Star Combo Pharma (ASX:S66) has a Days Inventory of 88.17 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Star Combo Pharma and its competitors. This is 13% below median its historical median of 101.72. Over the past decade, Star Combo Pharma's Days Inventory has ranged from 56.13 to 174.01. According to the industry distribution chart, Star Combo Pharma ranks #1063 out of 1874 companies in the Consumer Packaged Goods industry, placing it in the top 56.7%.
Is Star Combo Pharma's Days Inventory too high?
Star Combo Pharma's current Days Inventory of 88.17 is 13% below median its 10-year median of 101.72. Over the past 10 years, this metric has ranged from a low of 56.13 to a high of 174.01. The Consumer Packaged Goods industry median Days Inventory is 83.04. Star Combo Pharma's value of 88.17 is 6.2% above this industry median. Based on the distribution chart, Star Combo Pharma ranks #1063 out of 1874 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Star Combo Pharma has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Star Combo Pharma's Days Inventory compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Star Combo Pharma ranks #1063 out of 1874 companies for Days Inventory. This places Star Combo Pharma in the lower half of its industry. The industry median Days Inventory is 83.04. Star Combo Pharma's value of 88.17 is 6.2% above this benchmark. Historically, Star Combo Pharma's own Days Inventory has ranged from 56.13 to 174.01 over the past decade. While the company's 10-year median is 101.72 vs. the industry median of 83.04, Star Combo Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Consumer Packaged Goods company?
The median Days Inventory among Consumer Packaged Goods companies is 83.04, based on 1,874 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Combo Pharma's current Days Inventory of 88.17 is 6.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Star Combo Pharma and its competitors. For the Consumer Packaged Goods industry, the median Days Inventory is 83.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Combo Pharma's current Days Inventory is 88.17, which is 13% below median its own 10-year median of 101.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Combo Pharma stock overvalued right now?
Based on GuruFocus' analysis, Star Combo Pharma (ASX:S66) is currently considered Fairly Valued. The stock's GF Value™ is A$0.13, compared to a current price of A$0.13 — trading right at its estimated fair value. The current Days Inventory is 88.17, which is 13% below median its 10-year median of 101.72 and 6.2% above the Consumer Packaged Goods industry median of 83.04. Star Combo Pharma's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Star Combo Pharma (ASX:S66), the current Days Inventory is 88.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Combo Pharma (ASX:S66) Overvalued in 2026?
Based on GuruFocus' analysis, Star Combo Pharma stock appears to be undervalued.
The current stock price of A$0.13 is trading 0% below its estimated GF Value™ of A$0.13.
GuruFocus considers Star Combo Pharma to be Fairly Valued.
Key valuation signals for ASX:S66:
Days Inventory: 88.17 (13% below median its 10-year median of 101.72)
GF Value™: A$0.13 vs. price of A$0.13 (0% below fair value)
Industry Position: 6.2% above the Consumer Packaged Goods median (#1063 of 1874)
No single metric tells the full story. See the ASX:S66 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as Costar, Living Healthy, Amax, and J&K. It operates in two segments. The Star Combo segment engages in the development, manufacturing, marketing, and sales of natural health supplements and skincare products. The Austoyou retail business segment consists of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers, and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.
35GF Score
Get the complete analysis for ASX:S66
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:S66 has been successfully added to your 
